LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Search

Quidel Corp

Geschlossen

13 -0.69

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

12.82

Max

13.11

Schlüsselkennzahlen

By Trading Economics

Einkommen

39M

-92M

Verkäufe

-104M

620M

Gewinnspanne

-14.811

Angestellte

6,500

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-7.96% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

4. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-12M

688M

Vorheriger Eröffnungskurs

13.69

Vorheriger Schlusskurs

13

Quidel Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Mai 2026, 23:08 UTC

Akquisitionen, Fusionen, Übernahmen

Family Offices Bypass Private Equity and Go Direct -- Barrons.com

29. Mai 2026, 23:06 UTC

Akquisitionen, Fusionen, Übernahmen

After a Series of Sales, Hims Director Buys Company Shares -- Barrons.com

29. Mai 2026, 20:53 UTC

Ergebnisse

Oil Declines Lift Stocks to Fresh Records -- WSJ

29. Mai 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 20:33 UTC

Market Talk

Canada Meets Only One of Three Criteria To Declare Recession -- Market Talk

29. Mai 2026, 20:11 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 19:47 UTC

Ergebnisse

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

29. Mai 2026, 19:36 UTC

Market Talk

U.S. Natural Gas Futures End Month With Gains -- Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Over Half of Canadian Industries Growing, Undermining Recession Talk -- Market Talk

29. Mai 2026, 19:22 UTC

Market Talk

Oil Falls as U.S., Iran Expected to Reach Agreement -- Market Talk

29. Mai 2026, 19:05 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Takeover Bid From Bill Ackman's Pershing Square -- Barrons.com

29. Mai 2026, 18:19 UTC

Market Talk

Canada Technical Recession Chatter Rife But Per-Capita GDP Was Up -- Market Talk

29. Mai 2026, 18:12 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman -- WSJ

29. Mai 2026, 18:11 UTC

Market Talk

Canada Households Reaching Limit at Keeping Spending in Positive Territory -- Market Talk

29. Mai 2026, 18:10 UTC

Market Talk

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29. Mai 2026, 17:55 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 17:55 UTC

Market Talk

NEAR Protocol Nearly Doubles in May -- Market Talk

29. Mai 2026, 17:38 UTC

Market Talk

U.S. Oil Rig Count Rises for Fifth Straight Week -- Market Talk

29. Mai 2026, 17:00 UTC

Ergebnisse

Okta Stock Soars After Earnings. Results Aren't the Real Catalyst. -- Barrons.com

29. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

29. Mai 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29. Mai 2026, 16:02 UTC

Market Talk

Gold Extend Gains as Investors Await U.S.-Iran Deal News -- Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Global Equities Roundup: Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Cryptocurrencies Appear Detached From Stocks -- Market Talk

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Cormetech Acquisition to Drive Growth

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Demand for AI Data Centers Insatiable

29. Mai 2026, 15:40 UTC

Market Talk

Kalshi To Launch Crypto Perpetual Futures -- Market Talk

29. Mai 2026, 15:20 UTC

Market Talk

Canada's Economy Not Looking All That Bright -- Market Talk

Peer-Vergleich

Kursveränderung

Quidel Corp Prognose

Kursziel

By TipRanks

-7.96% Nachteil

12-Monats-Prognose

Durchschnitt 12.03 USD  -7.96%

Hoch 13 USD

Tief 11 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Quidel Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

1

Buy

4

Halten

1

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

Betriebsergebnis

$

Über Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat